High-Grade Squamous Intraepithelial Lesions
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Seeking subjects diagnosed with HSIL of the Cervix
Study Length: 85 Days
Target Age/Sex: 25 to 50 year old Female Subjects
Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.